These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25359301)

  • 1. The risk of breast cancer associated with specific patterns of migraine history.
    Lowry SJ; Malone KE; Cushing-Haugen KL; Li CI
    Cancer Causes Control; 2014 Dec; 25(12):1707-15. PubMed ID: 25359301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine in postmenopausal women and the risk of invasive breast cancer.
    Mathes RW; Malone KE; Daling JR; Davis S; Lucas SM; Porter PL; Li CI
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3116-22. PubMed ID: 18990752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
    Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
    JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
    Rosenberg LU; Magnusson C; Lindström E; Wedrén S; Hall P; Dickman PW
    Breast Cancer Res; 2006; 8(1):R11. PubMed ID: 16507159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal hormone therapy and risk of clinical breast cancer subtypes.
    Slanger TE; Chang-Claude JC; Obi N; Kropp S; Berger J; Vettorazzi E; Braendle W; Bastert G; Hentschel S; Flesch-Janys D
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1188-96. PubMed ID: 19336542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
    Li CI; Chlebowski RT; Freiberg M; Johnson KC; Kuller L; Lane D; Lessin L; O'Sullivan MJ; Wactawski-Wende J; Yasmeen S; Prentice R
    J Natl Cancer Inst; 2010 Sep; 102(18):1422-31. PubMed ID: 20733117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between migraine and breast cancer risk: A systematic review and meta-analysis.
    Hesari E; Ahmadinezhad M; Arshadi M; Azizi H; Khodamoradi F
    PLoS One; 2022; 17(2):e0263628. PubMed ID: 35143585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.
    Williams LA; Nichols HB; Hoadley KA; Tse CK; Geradts J; Bell ME; Perou CM; Love MI; Olshan AF; Troester MA
    Cancer Causes Control; 2018 Jan; 29(1):25-32. PubMed ID: 29124544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
    Phipps AI; Li CI; Kerlikowske K; Barlow WE; Buist DS
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1643-54. PubMed ID: 20501751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years.
    Li CI; Daling JR; Tang MT; Haugen KL; Porter PL; Malone KE
    JAMA Intern Med; 2013 Sep; 173(17):1629-37. PubMed ID: 23921840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women.
    Li CI; Mathes RW; Malone KE; Daling JR; Bernstein L; Marchbanks PA; Strom BL; Simon MS; Press MF; Deapen D; Burkman RT; Folger SG; McDonald JA; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2030-4. PubMed ID: 19589913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.
    Li CI; Malone KE; Porter PL; Lawton TJ; Voigt LF; Cushing-Haugen KL; Lin MG; Yuan X; Daling JR
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):43-50. PubMed ID: 18199710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity in risk factors for ductal and lobular breast carcinomas: A case-control study.
    Dianatinasab M; Fararouei M; Daneshi N; Rezaian S; Mohammadianpanah M; Chaman R; Ghiasvand R
    Int J Cancer; 2019 Dec; 145(11):2917-2925. PubMed ID: 30719718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.
    Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Coates RJ; Marchbanks PA; Norman SA; Weiss LK; Ursin G; Berlin JA; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Wingo PA; Spirtas R
    Cancer; 2002 Dec; 95(12):2455-64. PubMed ID: 12467057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
    Gapstur SM; Morrow M; Sellers TA
    JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer.
    Li CI; Daling JR; Malone KE; Bernstein L; Marchbanks PA; Liff JM; Strom BL; Simon MS; Press MF; McDonald JA; Ursin G; Burkman RT; Deapen D; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):946-54. PubMed ID: 16702375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
    Li CI; Anderson BO; Daling JR; Moe RE
    JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between histamine2-receptor antagonist medications and risk of invasive breast cancer.
    Mathes RW; Malone KE; Daling JR; Porter PL; Li CI
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):67-72. PubMed ID: 18199712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.